Puretech Health

Puretech Health's reported carbon emissions

Puretech Health, a pharmaceutical preparation manufacturing company headquartered in the US, has reported its carbon emissions for several years. In 2024, the company's total emissions were approximately 139,300 kg CO2e. This comprised about 3,200 kg CO2e in Scope 1 emissions and approximately 60,500 kg CO2e in Scope 2 emissions (market-based). Scope 3 emissions accounted for roughly 75,600 kg CO2e in the same year. In 2023, Puretech Health's total emissions were around 166,700 kg CO2e, with Scope 1 at approximately 3,900 kg CO2e, Scope 2 at about 54,900 kg CO2e, and Scope 3 at approximately 108,000 kg CO2e. The company's emissions data shows a general downward trend in total emissions from 2018 to 2024, with total emissions decreasing from approximately 1,378,800 kg CO2e in 2018 to 139,300 kg CO2e in 2024. This significant reduction over the period is notable. Puretech Health is committed to climate action and has signed the Climate Pledge. This commitment, which involves the parent organisation PureTech Health plc, aims to achieve net-zero carbon emissions by 2040. While specific interim targets for emission reductions are not detailed here, their participation in the Climate Pledge signifies an ambition to align with global climate goals. The company's reporting typically covers Scope 1, 2, and 3 emissions, indicating a comprehensive approach to understanding and managing its environmental impact. It's noted that data for Scope 3 category "purchased goods and services" was missing in several reporting years.